Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Study Record Dates were updated with several entries changing from Estimated to Actual, and the revision tag was updated to Revision: v3.6.5, indicating a new version of the study record.
    Difference
    0.4%
    Check dated 2026-08-08T09:49:24.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.3 to v3.6.4, indicating a software update to the site's tooling. It appears to affect only versioning metadata, not the study details.
    Difference
    0.1%
    Check dated 2026-07-25T06:28:49.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance update. No visible study details or functionality appear to be altered.
    Difference
    0.1%
    Check dated 2026-07-03T22:39:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page software or documentation. No study content or user-facing information was altered.
    Difference
    0.1%
    Check dated 2026-06-26T22:55:16.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Added new navigation/help sections—How to Read a Study Record, Common Questions, and How to Join a Study—and a recruitment note stating No longer looking for participants. The Intervention / Treatment heading was normalized to Intervention/Treatment and the page revision stamp updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T13:34:21.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.5.5 indicates a minor page update. It does not change the clinical trial data, eligibility criteria, or how the page is used.
    Difference
    0.1%
    Check dated 2026-06-05T09:58:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.